PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance Gross margin for the third quarter 2025 was 65% compared to 63% in the prior year period. Gross margin expansion in the third quarter was due to improved operational efficiencies and overhead absorption, modestly offset by increased tariff expenses. Operating expenses in the third quarter of 2025 were $77.2 million, compared with$59.3 million in the prior year period. The increase in operating expenses was pri ...